Chapter 10: Navigating Recovery: Treatment Pathways and Ongoing Support

Chapter 10 — Module 4: Assessment and Support

From Assessment to Treatment: Recovery Pathways and Ongoing Support

Understanding how practitioners move from diagnosis to care planning — and how treatment, medication, support systems, and relapse prevention combine to support long-term recovery.

Once a concern has been identified, assessed, and a level of need established, which was the focus of Chapter 9, practitioners must connect people to care and then support the longer, often nonlinear work of recovery that extends well beyond any single treatment episode. This chapter addresses what comes next.

Figure 10.1. From Assessment to Sustained Recovery: A Treatment Pathway Overview

Flowchart of the treatment pathway; full description follows in the caption.

Note. Original figure created for this text.

This flowchart shows the treatment pathway described in the chapter. Screening and assessment from Chapter 9 leads to level-of-care matching, which ranges from outpatient to residential to inpatient. Care then branches into three approaches: behavioral, including motivational interviewing, cognitive behavioral therapy, and family therapy; environmental, including housing, peer support, and recovery capital; and medical, including medications and withdrawal management. Spiritual considerations connect to the behavioral branch when relevant to the client. All approaches lead to relapse prevention, which draws on the CENAPS and Marlatt models and coping skills, and then to sustained recovery that is ongoing, nonlinear, and person-defined.

Student Learning Outcomes

This chapter supports the following course objectives. By engaging with the material, students will work toward the ability to:

Integrate research literacy and evidence-informed frameworks to design individualized and group intervention strategies that address co-occurring disorders, recovery needs, and systemic barriers to treatment.

• Describe the main behavioral, medication, and peer-support approaches to treating substance use disorders.
• Explain relapse prevention as part of long-term, often nonlinear recovery rather than a sign of failure.

Apply collaborative, strengths-based assessment and planning methods to coordinate care across health, justice, and social systems, incorporating family and community engagement as essential components of recovery-oriented practice.

• Match a person to an appropriate level of care based on need and circumstances.
• Recognize the role of family, peers, and community in sustaining recovery over time.

Council on Social Work Education (CSWE) Competencies Addressed

Competency 6: Engage with Individuals, Families, Groups, Organizations, and Communities
Competency 7: Assess Individuals, Families, Groups, Organizations, and Communities
Competency 8: Intervene with Individuals, Families, Groups, Organizations, and Communities
Competency 9: Evaluate Practice with Individuals, Families, Groups, Organizations, and Communities


Section 10.1 — Basic Principles of Substance Use Disorder Treatment

Read this section+

Chapter 9 focused on screening, assessment, and the conditions that frequently co-occur with substance use disorders. This chapter asks what comes next. After a person has been identified, assessed, and diagnosed, practitioners face the practical question of how to connect them to effective care, and how to support the longer work of recovery once formal treatment ends. The vocabulary shifts here as well: the earlier chapters use substance misuse for use that causes harm without assuming a diagnosis, while this half of the book works mostly with substance use disorder, because treatment and service systems respond to a diagnosed condition.

Substance use disorder treatment is not a single event. It is a continuum of services that should be matched to the individual’s clinical needs, personal circumstances, and available resources. Treatment may be brief or extended, outpatient or residential, focused primarily on behavioral change or on medical stabilization. What matters is that the approach fits the person rather than the reverse (Psych Central, 2021).

Effective treatment addresses more than substance use alone. Co-occurring mental health conditions, physical health concerns, family relationships, housing stability, employment, legal involvement, and financial stressors all influence whether recovery takes hold. Diagnosis helps guide care planning, but it does not define the person or determine the outcome.

Three Treatment Orientations

Most treatment approaches draw on one or more of three broad orientations. The psychological model focuses on the emotional and behavioral patterns that contribute to substance use, including trauma, coping deficits, learned reinforcement, and cognitive distortions. The medical model focuses on the biological dimensions of substance use disorder, including withdrawal management, neurological dependence, and the use of medication to support recovery. The sociocultural model focuses on the person’s environment, relationships, cultural identity, and community context as both sources of risk and as resources for recovery. Chapter 2 examined each of these orientations in depth, along with the evidence and assumptions behind them.

These are not competing explanations. Most people in treatment benefit from approaches that draw on more than one orientation. A person managing opioid withdrawal needs medical support. The same person may also need trauma-informed counseling and a recovery-supportive living environment. Understanding these orientations helps practitioners recognize that no single approach is sufficient for every individual.

Treatment works best when it is matched to the person, not the diagnosis. The goal is to meet people where they are with the level of care and type of support most likely to help them move forward.


Section 10.2 — Level of Care: Matching Treatment to Need

Read this section+

Not everyone with a substance use disorder requires the same level of care. One of the central tasks of treatment planning is matching the person to the most effective and least restrictive setting available. A higher level of intensity is not automatically better; it should be justified by clinical need. Likewise, residential care is a tool, not a destination. The goal is always to support the person in building the conditions for stable, independent recovery rather than extending intensive treatment beyond what the situation requires.

The American Society of Addiction Medicine (ASAM) provides a widely used framework for level-of-care decisions. Rather than basing placement solely on the severity of substance use, the third edition of the ASAM criteria considers six dimensions: withdrawal risk, biomedical conditions, emotional and behavioral concerns, readiness for change, relapse or continued use potential, and recovery environment. This multidimensional approach reflects the reality that two people with the same diagnosis may require very different levels of support (Mee-Lee et al., 2013).

Levels of Care

Outpatient treatment involves scheduled sessions, typically individual counseling, group therapy, or both, while the person continues living at home. It is appropriate for people with mild to moderate disorder who have stable housing, strong social support, and manageable withdrawal risk.

Intensive outpatient treatment (IOP) provides a higher level of structure and contact, typically nine or more hours per week, without requiring residential placement. IOP is often used as a step-down following residential treatment or as a step-up for those who are not progressing in standard outpatient care.

Residential treatment provides structured, 24-hour care in a non-hospital setting. Licensed residential programs are most appropriate for people who have not been able to maintain recovery in outpatient settings, who face significant environmental instability, or whose co-occurring conditions require intensive daily support. Therapeutic communities represent one residential model in which the community structure itself, meaning the relationships, expectations, and shared accountability among residents, serves as a primary mechanism of change. Short-term residential programs may focus primarily on stabilization and transition planning rather than comprehensive treatment.

Inpatient hospitalization is the most intensive level of care, appropriate when a person requires medical monitoring during withdrawal, has co-occurring psychiatric conditions requiring stabilization, or presents significant safety concerns.

Withdrawal management (detoxification) addresses the medical process of clearing substances from the body safely. It is not treatment in itself; it prepares a person for treatment by managing acute withdrawal symptoms and reducing immediate physical risk.

Recovery housing provides structured, substance-free living environments that support the transition from formal treatment back into independent community life. Sober living homes, Oxford Houses, and structured recovery residences vary in their level of support, but all share the goal of providing environmental stability during early recovery when relapse risk is highest (Substance Abuse and Mental Health Services Administration [SAMHSA], 2020). Research shows that stable, recovery-oriented housing is associated with lower substance use and better long-term recovery outcomes (Jason et al., 2006).

People may move up or down this continuum depending on their current needs. A person who begins in outpatient treatment and experiences a crisis may need a temporary step up to a higher level of care. A person completing residential treatment moves to less intensive outpatient support or recovery housing as stability improves. Continuity across these transitions is itself a treatment goal (Psych Central, 2021).


Section 10.3 — Psychological and Behavioral Treatment Approaches

Read this section+

Psychological and behavioral treatment approaches address the thoughts, emotions, and behaviors that drive substance use and that must change for recovery to take hold. These approaches vary in their specific focus, but all share the goal of helping individuals develop the insight, skills, and motivation to build a different relationship with substances.

Motivational Interviewing

Motivational interviewing (MI) is a client-centered, goal-oriented method of communication designed to strengthen a person’s own motivation for change by exploring and resolving ambivalence. Developed by Miller and Rollnick (2013), MI does not argue the client toward change. It helps clients articulate their own reasons for changing, drawing out what are called change talk statements. In its current formulation, MI unfolds through four overlapping processes—engaging, focusing, evoking, and planning—while retaining its core spirit of expressing empathy, evoking the client’s own motivation, and supporting self-efficacy.

Ambivalence is central to MI. People with substance use disorders often recognize on some level that their use is harmful while also fearing the prospect of changing. MI treats this ambivalence as normal and works with it rather than against it. Practitioners who instead confront resistance directly typically increase it.

Supplementary Viewing

The Suspicious Smoker: The Guiding Style of Motivational Interviewing

A short demonstration by Stephen Rollnick, co-author of the motivational interviewing text, using directional open questions and reflections to evoke change talk and closing with a summary.

Watch: The Suspicious Smoker, Part 3

Cognitive Behavioral Therapy

Cognitive behavioral therapy (CBT) is among the most extensively researched approaches in substance use treatment. CBT focuses on the relationship between thoughts, emotions, and behavior, helping individuals identify the triggers and thought patterns that precede substance use and develop more effective coping responses. Skills taught in CBT include recognizing high-risk situations, challenging distorted thinking, managing emotional distress, and building behavioral alternatives to substance use (McHugh et al., 2010).

Other Evidence-Informed Approaches

Motivational enhancement therapy (MET) applies MI principles in a brief, structured format using feedback from assessment results to enhance motivation for change. Contingency management uses positive reinforcement, typically vouchers or privileges, to reward substance-free behavior, and has shown effectiveness particularly for stimulant use disorders (Prendergast et al., 2006). Family therapy approaches address the relational systems surrounding a person’s substance use, recognizing that recovery affects everyone in the family and that family involvement improves outcomes (Rowe, 2012). Seeking Safety is a structured, evidence-informed model developed specifically for people managing both post-traumatic stress disorder (PTSD) and substance use disorder simultaneously (Najavits, 2002).

For students in an introductory course, the key point is not to memorize each approach in detail. It is to recognize that effective treatment draws on multiple methods tailored to the individual’s needs, readiness, and context. No single approach works for everyone, and effective practitioners maintain a working knowledge of the range of options rather than applying the same framework to every situation.

Effective treatment is not about applying the best technique. It is about developing the best fit between a person’s current needs and the approaches most likely to help them at this point in their recovery journey.


Section 10.4 — Medications for Substance Use Disorder Treatment

Read this section+

Medications are an important and often underused part of substance use disorder treatment. They can help manage withdrawal symptoms, reduce cravings, block the reinforcing effects of substances, and support long-term recovery maintenance. For some individuals, particularly those with severe opioid use disorder, medication is not an alternative to recovery; it is what makes sustained recovery possible.

Medications approved by the Food and Drug Administration (FDA) exist for opioid use disorder, alcohol use disorder, and nicotine use disorder. This approach was long called medication-assisted treatment (MAT). The profession has moved toward medications for opioid use disorder (MOUD), because assisted implies that medication supports the real treatment rather than being a primary treatment in its own right. Both terms remain in circulation, and practitioners should recognize both. Despite strong evidence supporting their effectiveness, these medications remain underused because of persistent stigma, particularly the characterization of opioid use disorder medications as simply substituting one drug for another. This framing misrepresents how these medications work. Medications like buprenorphine and methadone stabilize neurological function, eliminate withdrawal, and reduce craving at doses that do not produce intoxication. Treating them as equivalent to active addiction is both scientifically inaccurate and clinically harmful (National Academies of Sciences, Engineering, and Medicine, 2019).

Table 10.1. FDA-Approved Medications for Opioid and Alcohol Use Disorders

Medication Primary use How it works
Opioid Use Disorder
Methadone Opioid use disorder Full opioid agonist; reduces cravings and withdrawal; dispensed daily at licensed clinics
Buprenorphine Opioid use disorder Partial agonist; reduces cravings and withdrawal; can be prescribed in office-based settings
Naltrexone Opioid use disorder Opioid antagonist; blocks euphoric effects; available as oral tablet or monthly injection (Vivitrol)
Alcohol Use Disorder
Naltrexone Alcohol use disorder Reduces craving and reward response to alcohol
Acamprosate Alcohol use disorder Reduces post-acute withdrawal symptoms; supports abstinence maintenance
Disulfiram Alcohol use disorder Causes aversive reaction if alcohol is consumed; requires strong motivation and monitoring

Note. Data from U.S. Food and Drug Administration (2023) approved indications for medications for opioid and alcohol use disorder.

Treatment with medication is most effective when integrated with counseling, peer support, and recovery planning. Medication decisions should be individualized, taking into account the person’s substance use history, co-occurring conditions, previous treatment experiences, and personal goals.

Supplementary Reading

Medication-Assisted Treatment

An overview of FDA-approved medications for substance use disorders, including mechanisms and appropriate use.

FDA: Information About MAT

Supplementary Reading

MAT Overview — SAMHSA

SAMHSA’s overview of medications for opioid and alcohol use disorders with access and referral resources.

SAMHSA: Medication-Assisted Treatment

Practitioners working in settings where medication is available should be able to explain these options accurately, address common misconceptions, and actively support clients in accessing medical providers. Allowing medication stigma to shape practice recommendations is itself a clinical harm.


Section 10.5 — Support Groups, Peer Support, and Self-Care

Read this section+

Formal treatment is typically time-limited. Recovery is not. The conditions that sustain long-term recovery, such as stable housing, meaningful social connection, employment, health, and a sense of purpose, must be built and maintained far beyond the boundaries of any treatment episode. This is the domain of recovery support.

Recovery Capital

Recovery capital refers to the personal, social, and community resources that support long-term recovery. Personal recovery capital includes health, coping skills, values, and self-efficacy. Social recovery capital includes family support, peer relationships, and connection to affirming communities. Community recovery capital includes access to housing, employment, transportation, healthcare, and culturally responsive services (White & Cloud, 2008). Building recovery capital is not supplementary to treatment; it is what makes recovery durable. Section 14.2 develops this framework further, dividing recovery capital into four domains rather than three.

Support Groups

Twelve Step programs such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) are among the most widely used recovery support resources in the United States. Active involvement, particularly through sponsorship, service, and regular attendance, is associated with improved long-term recovery outcomes (Kaskutas et al., 2002). Twelve Step programs incorporate spiritual concepts and encourage members to define a Higher Power in whatever way is personally meaningful, making them accessible to a range of belief systems.

Twelve Step programs do not work for everyone, and effective practice requires familiarity with secular alternatives. SMART Recovery (Self-Management and Recovery Training) uses cognitive-behavioral principles and does not incorporate spiritual language. LifeRing Secular Recovery and Secular Organizations for Sobriety offer community-based support without religious framing. The existence of multiple pathways reflects the core recovery principle that no single approach works for all people.

Resource

SMART Recovery

A secular, evidence-based recovery support program using cognitive-behavioral tools and peer community.

smartrecovery.org

Resource

What Is an AA Meeting?

An accessible overview of what happens in an AA meeting, useful context for students who have not attended one.

Watch on YouTube

Peer Support Services

Peer recovery support services, provided by individuals with lived experience of substance use disorder, are an emerging and increasingly recognized component of recovery-oriented systems of care. Peer specialists offer a distinctive form of connection and credibility grounded in shared experience. They provide mentoring, coaching, navigation of treatment systems, and the practical demonstration that recovery is possible, though the evidence base for these services is still developing (Eddie et al., 2019).

Self-Care and Meaningful Engagement

Recovery is not only the absence of substance use; it is the presence of conditions that make a meaningful life possible without it. Exercise, sleep, nutrition, connection to others, purposeful activity, and engagement in creative or spiritual practices all contribute to the neurological and psychological stability that recovery requires. Practitioners can support clients in building these conditions as active components of care rather than treating them as peripheral lifestyle choices.


Section 10.6 — Relapse Prevention and Recurrence Planning

Read this section+

Recurrence of substance use following a period of abstinence is one of the most consistent findings in the treatment literature. Research has found that 40 to 60 percent of individuals treated for substance use disorders return to some level of use within the first year, a rate the National Institute on Drug Abuse (2020) presents alongside annual recurrence rates of 50 to 70 percent for hypertension and asthma. The study behind that figure stated it from the other direction, reporting that 40 to 60 percent of patients were continuously abstinent one year after discharge, and its argument was that recurrence in substance use disorders is similar to recurrence in other chronic illnesses rather than uniquely high (McLellan et al., 2000). Practitioners in every setting, not only formal treatment programs, need to understand how to help clients prevent recurrence and, when it occurs, keep it from escalating.

Language matters here. The term relapse carries clinical and historical weight, but it also carries stigma. Some contemporary frameworks use recurrence to describe the return of substance use, in the same way that recurrence is used for other chronic conditions like diabetes or hypertension. Students should be familiar with both terms. The shift is not merely semantic; it reflects a broader movement toward treating substance use disorder as a health condition rather than a moral or personal failure.

Slip Versus Relapse

A slip is a single episode of substance use following a period of abstinence. A relapse or recurrence is the return to uncontrolled use. The distinction matters clinically. When a person believes a slip means they have “blown everything,” the resulting guilt and hopelessness can be what drives the escalation, not the substance use itself. Helping clients understand and plan for slips in advance is a protective clinical strategy, not a license to use.

Two Models of Relapse Prevention

Gorski’s CENAPS model (named for the Center for Applied Sciences) approaches relapse prevention from within the disease framework. It conceptualizes relapse as a process in which internal warning signs, including mistaken beliefs and emotional and behavioral deterioration, build well before substance use occurs. Recovery unfolds through a six-stage developmental model, from transition and stabilization through late recovery and maintenance. A key feature of the CENAPS model is its prerequisite: clients must first complete the primary goals of treatment before entering formal relapse prevention programming (Gorski, 1993).

Marlatt’s cognitive-social learning model does not require prior acceptance of the disease framework. It treats addictive behaviors as learned habits and focuses on the role of self-efficacy, a person’s belief in their own ability to manage a high-risk situation. When self-efficacy is low, the probability of use increases. In the taxonomy of high-risk situations that underpins this model, negative emotional states and interpersonal conflict together triggered more than half of all relapse episodes, and social pressure contributed to more than 20 percent (Larimer et al., 1999).

Marlatt also identifies the abstinence violation effect (AVE), the guilt, shame, and self-blame that follow a slip and that can transform a single use episode into full recurrence. Related to this are apparently irrelevant decisions (AIDs): small choices that seem unrelated to substance use but that covertly move a person toward a high-risk situation.

Table 10.2. Comparing the CENAPS and Cognitive-Social Learning Models of Relapse Prevention

Dimension Gorski’s CENAPS Model Marlatt’s Cognitive-Social Learning Model
Underlying philosophy Addiction as a biopsychosocial disease; aligned with disease model Addictive behaviors as learned habits subject to the same change principles as any behavior
Client prerequisite Must complete “primary goals” of treatment first No prerequisite; applicable to anyone seeking to maintain a behavior change
Key relapse concept Relapse begins with illogical core beliefs and progresses through emotional and behavioral warning signs Abstinence violation effect (AVE): guilt and shame following a slip can escalate to full relapse
Lifestyle focus Personality, family functioning, and cognitive patterns require change alongside abstinence Lifestyle imbalance (“shoulds” outweighing “wants”) creates covert pathways to high-risk situations
Primary techniques Self-assessment, warning sign identification, cognitive-affective-behavioral strategies, family involvement High-risk situation hierarchy, self-efficacy building, coping skills training, AID recognition

Note. Adapted from Gorski’s CENAPS model of relapse prevention (Gorski, 1993) and Marlatt’s cognitive-social learning model of relapse (Cummings et al., 1980; Larimer et al., 1999).

Essential Strategies

Regardless of which model guides practice, effective relapse prevention involves several shared components. High-risk situation assessment identifies the specific circumstances most likely to precede use for that individual. Coping strategies are developed at situational-behavioral, cognitive-affective, and core psychological levels. Urge and craving management techniques, including self-talk, activity substitution, and social support contact, are practiced before they are needed. Relapse contracts establish in advance what a client will do if a slip occurs, reducing the likelihood that shame will prevent them from reaching out.

For generalist practitioners in schools, agencies, and community settings, this work may represent the most sustained contact a client has with a helping professional after formal treatment ends. Familiarity with these strategies is not optional. If substance use disorder is a chronic condition rather than an acute one, as McLellan et al. (2000) argued, then supporting a person through recurrence is not a specialty skill. It is a core practice competency.

Relapse prevention is not about assuming failure. It is about building enough preparedness that if a slip occurs, the client has something to reach for, rather than a reason to give up.

Supplementary Reading

Relapse Prevention: Marlatt’s Cognitive-Behavioral Model

Overview of Marlatt’s model including high-risk situations, coping strategies, and the abstinence violation effect.

Larimer et al. (1999)

Supplementary Reading

Melemis on Relapse Prevention

A practical clinical overview of relapse prevention strategies and their application across settings.

Melemis — Relapse Prevention


Section 10.7 — Spirituality, Religion, and Recovery

Read this section+

Spirituality and religion are potential recovery resources for some individuals, not universal treatment components. Their role in any given person’s recovery must be assessed rather than assumed. Both realities must be held simultaneously: faith can be a meaningful source of strength in recovery, and religious institutions can be sources of judgment, exclusion, and shame. Effective practice requires attending to both.

The historical relationship between religion and substance use in the United States has not always been positive. For much of American history, addiction was framed through the moral model, which understood substance use as evidence of weak character or spiritual failure rather than a health condition. Recovery was framed as personal reform or spiritual conversion. While the moral model offered a simple explanation, it left no room for understanding the biological, psychological, social, and environmental factors that contribute to substance use disorders, and it contributed to stigma and criminalization that caused lasting harm (Capuzzi et al., 2016).

Dismissing spirituality because of this history would overlook something genuine. Research suggests that spiritual and religious involvement can serve as a protective factor for some people, operating through the meaning found in personal beliefs, the practices that reinforce those beliefs, and the sense of belonging that comes from connection to a supportive community (Grim & Grim, 2019). A research handbook that counted studies examining faith involvement found a protective association with substance-related outcomes in 240 of 278 alcohol studies and 155 of 185 drug studies, roughly 86 and 84 percent (Koenig et al., 2012). That tally counts how consistently the association appears across observational studies rather than pooling their effect sizes, so it says nothing about how large the association is. That association is not universal, and it depends heavily on whether the surrounding community is affirming rather than shaming.

This distinction is particularly important with marginalized populations. Carrico et al. (2017) found that among young Black men who have sex with men, higher spiritual coping was associated with lower odds of stimulant use, whereas greater engagement in religious and spiritual activities was associated with higher odds of stimulant use—a reminder that religiosity is not uniformly protective and that its effect depends on how it is experienced. Spirituality cannot be assessed apart from the social context in which it is experienced.

Recovery support programs reflect this diversity. Twelve Step programs incorporate spiritual language but are not tied to any particular religion. Explicitly faith-based programs such as Celebrate Recovery exist alongside secular alternatives that provide the same structure, accountability, and community without spiritual framing. Multiple pathways are valid. Client self-determination is the operative principle.

Alcoholics Anonymous remains one of the most widely used recovery support resources in the United States. Participants define a Higher Power in whatever way is meaningful to them, religious or otherwise. Active engagement, including sponsorship, service, and regular attendance, is associated with improved outcomes (Kaskutas et al., 2002; Tonigan et al., 1996).

For practitioners, spiritual assessment is part of culturally responsive care. Hodge (2006b) offers a straightforward set of orienting questions: whether spirituality or religion is important to the client, whether specific beliefs support coping, whether community involvement exists, and whether any spiritual concerns should be addressed in treatment. When clients identify spirituality as relevant, practitioners can incorporate it by translating therapeutic goals into language that reflects the client’s own values and sources of meaning, without imposing beliefs or treating any particular pathway as superior (Hodge, 2006a).

Secular recovery is equally valid and should be named explicitly, not treated as a fallback for people who “don’t do the spiritual stuff.” SMART Recovery, LifeRing, and Secular Organizations for Sobriety provide community, structure, and accountability grounded in cognitive-behavioral and self-determination principles rather than spiritual frameworks.

Spirituality should be assessed, not assumed. The practitioner’s responsibility is to understand what sources of meaning, community, and hope are present in the client’s life, and to support those resources when they serve the client’s own recovery goals.


Section 10.8 — Learning from Lived Experience

Read this section+

Research and clinical frameworks provide an essential foundation for understanding substance use disorders. They explain what research has taught us about addiction, recovery, and effective treatment. At the same time, they cannot fully capture what it is like to experience substance use firsthand or to navigate the challenges of recovery. That perspective comes from listening to people who have lived it.

Personal recovery stories add an important dimension to what you have learned in this chapter. They remind us that no two people arrive at addiction for the same reasons. No two people recover in exactly the same way. Every person’s journey is shaped by different circumstances and different turning points. Each story offers another opportunity to better understand the realities that individuals face as they work toward recovery.

As you engage with lived experience presentations, think about how each person’s story connects with the concepts discussed throughout this chapter. Consider what influenced the person’s decision to seek help. Reflect on how treatment shaped the recovery process. Notice the role of relationships and community. Pay attention to the effects of stigma. Finally, compare what you hear with the evidence presented throughout this chapter. Research identifies common patterns, but every recovery journey is unique.

Supplementary Viewing

TEDx Presentation: Addiction: A Story of Stigma, A Story of Hope

Scott McFadden shares his perspective as both a licensed addiction counselor and a person in long-term recovery. His presentation illustrates how stigma can shape the way addiction is understood and treated. As you watch, consider how his experiences reinforce or challenge the concepts presented throughout this chapter.

Watch the TEDx Presentation

Treatment is where recovery begins. The real work, rebuilding relationships, finding purpose, developing stability, and learning to live differently, happens in the days, months, and years that follow. Practitioners who understand that are better prepared for the long arc of the work.

Summary

This chapter moved from assessment into treatment and the long work of recovery. It began with the basic principles of effective treatment, then explained how practitioners match a person to a level of care, from outpatient through residential and detoxification. It covered the main behavioral approaches, including motivational interviewing, cognitive behavioral therapy, contingency management, and family therapy, and the medications that make sustained recovery possible for many people. The chapter then turned to support groups, peer support, and recovery capital, the conditions outside formal treatment that keep recovery durable. It treated relapse not as failure but as a common part of a nonlinear process that practitioners can plan for, and it considered the role of spirituality and meaning for those who draw on them. It closed by emphasizing what lived experience can teach us about the realities of recovery and the importance of listening to the people whose lives are directly affected.

Key Terms

Show key terms+

Cognitive behavioral therapy. A treatment approach that examines the links between thoughts, emotions, and behavior to change patterns connected to substance use.

Contingency management. An approach that uses positive reinforcement, such as vouchers or privileges, to reward substance-free behavior.

Detoxification. Medically supervised management of withdrawal that prepares a person for treatment rather than serving as treatment itself.

Level of care. The intensity and setting of treatment, ranging from outpatient sessions to residential programs, matched to a person’s need.

Medications for opioid use disorder (MOUD). Medications that reduce cravings or withdrawal and support sustained recovery. Approved medications also exist for alcohol use disorder and nicotine use disorder.

Motivational interviewing. A collaborative, goal-oriented counseling style that strengthens a person’s own motivation and commitment to change by exploring and resolving ambivalence.

Peer recovery support. Support provided by people with lived experience of substance use disorder, offering connection and credibility that complement formal treatment.

Recovery. An ongoing, individually defined process of change through which a person improves health and wellness and works toward their own goals, possible even after years of untreated symptoms.

Recovery capital. The personal, social, and community resources, such as stable housing, relationships, and purpose, that make recovery durable.

Relapse prevention. Planning and skills that help a person anticipate triggers and keep a return to use from escalating, treating recurrence as part of recovery rather than failure.


Where This Leads

Treatment and recovery rarely involve substance use alone. Many people in care are also living with mental health conditions, and the two shape each other in ways that change what effective treatment looks like.

Chapter 11 takes up co-occurring disorders: how to recognize them, why they complicate diagnosis, and why integrated treatment that addresses substance use and mental health together is the evidence-based standard. Where this chapter built the treatment toolkit, the next one applies it to the people who carry more than one condition at once.

Further Reflection

Treatment is where recovery begins, not where it is completed. What does that imply for how success is measured?
Matching level of care to need sounds straightforward and often fails in practice. What gets in the way?
Recurrence is common in chronic conditions. How should a practitioner respond to it without treating it as failure?

Attributions

Sections 10.1 through 10.6 and 10.8 are original content developed for this text. Section 10.7 is an adaptation of “Ch. 6.1” and “Ch. 6.2” in Introduction to Substance Use Disorders by Patricia Stoddard Dare and Audrey Begun, licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Additional commentary, contextual framing, and instructional modifications have been incorporated to align the material with the objectives and structure of this text.

Bibliography

Show references+

Note: Sections 10.1–10.6 and 10.8 are original content developed for this text. Section 10.7 adapts “Ch. 6.1” and “Ch. 6.2” from Introduction to Substance Use Disorders by Patricia Stoddard Dare and Audrey Begun, licensed under CC BY-NC, and adds original commentary, framing, and sources developed for this text. References drawn from the adapted source and those added here are listed together below.

Capuzzi, D., Stauffer, M. D., & Sharpe, C. (2016). History and etiological models of addiction. In D. Capuzzi & M. D. Stauffer (Eds.), Foundations of addictions counseling (3rd ed., pp. 1–17). Pearson.

Carrico, A. W., Storholm, E. D., Flentje, A., Arnold, E. A., Pollack, L. M., Neilands, T. B., Rebchook, G. M., Peterson, J. L., Eke, A., Johnson, W., & Kegeles, S. M. (2017). Spirituality/religiosity, substance use, and HIV testing among young black men who have sex with men. Drug and Alcohol Dependence, 174, 106–112. https://doi.org/10.1016/j.drugalcdep.2017.01.024

Cummings, C., Gordon, J. R., & Marlatt, G. A. (1980). Relapse: Prevention and prediction. In W. R. Miller (Ed.), The addictive behaviors: Treatment of alcoholism, drug abuse, smoking, and obesity (pp. 291–321). Pergamon Press.

Eddie, D., Hoffman, L., Vilsaint, C., Abry, A., Bergman, B., Hoeppner, B., Weinstein, C., & Kelly, J. F. (2019). Lived experience in new models of care for substance use disorder. Frontiers in Psychology, 10, Article 1052. https://doi.org/10.3389/fpsyg.2019.01052

Gorski, T. T. (1993). Passages through recovery: An action plan for preventing relapse. Hazelden.

Grim, B. J., & Grim, M. E. (2019). Belief, behavior, and belonging: How faith is indispensable in preventing and recovering from substance abuse. Journal of Religion and Health, 58(5), 1713–1750. https://doi.org/10.1007/s10943-019-00876-w

Hodge, D. R. (2006a). Spiritually modified cognitive therapy: A review of the literature. Social Work, 51(2), 157–166.

Hodge, D. R. (2006b). A template for spiritual assessment: A review of the JCAHO requirements and guidelines for implementation. Social Work, 51(4), 317–326.

Jason, L. A., Olson, B. D., Ferrari, J. R., & Lo Sasso, A. T. (2006). Communal housing settings enhance substance abuse recovery. American Journal of Public Health, 96(10), 1727–1729. https://doi.org/10.2105/AJPH.2005.070839

Kaskutas, L. A., Bond, J., & Humphreys, K. (2002). Social networks as mediators of the effect of Alcoholics Anonymous. Addiction, 97(7), 891–900.

Koenig, H. G., King, D. E., & Carson, V. B. (2012). Handbook of religion and health (2nd ed.). Oxford University Press.

Larimer, M. E., Palmer, R. S., & Marlatt, G. A. (1999). Relapse prevention: An overview of Marlatt’s cognitive-behavioral model. Alcohol Research & Health, 23(2), 151–160.

McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010). Cognitive behavioral therapy for substance use disorders. Psychiatric Clinics of North America, 33(3), 511–525.

McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689

Mee-Lee, D., Shulman, G. D., Fishman, M. J., Gastfriend, D. R., & Miller, M. M. (Eds.). (2013). The ASAM criteria: Treatment criteria for addictive, substance-related, and co-occurring conditions (3rd ed.). American Society of Addiction Medicine.

Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.

Najavits, L. M. (2002). Seeking safety: A treatment manual for PTSD and substance abuse. Guilford Press.

National Academies of Sciences, Engineering, and Medicine. (2019). Medications for opioid use disorder save lives. The National Academies Press.

National Institute on Drug Abuse. (2020). Drugs, brains, and behavior: The science of addiction. U.S. Department of Health and Human Services, National Institutes of Health. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction

Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006). Contingency management for treatment of substance use disorders: A meta-analysis. Addiction, 101(11), 1546–1560. https://doi.org/10.1111/j.1360-0443.2006.01581.x

Psych Central. (2021). Treating substance use disorders. https://psychcentral.com/addictions/substance-use-disorders-treatment/

Rowe, C. L. (2012). Family therapy for drug abuse: Review and updates 2003–2010. Journal of Marital and Family Therapy, 38(1), 59–81. https://doi.org/10.1111/j.1752-0606.2011.00280.x

Substance Abuse and Mental Health Services Administration. (2020). Recovery housing: Best practices and suggested guidelines. U.S. Department of Health and Human Services.

Tonigan, J. S., Toscova, R., & Miller, W. R. (1996). Meta-analysis of the literature on Alcoholics Anonymous: Sample and study characteristics moderate findings. Journal of Studies on Alcohol, 57(1), 65–72.

U.S. Food and Drug Administration. (2023). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud

White, W. L., & Cloud, W. (2008). Recovery capital: A primer for addictions professionals. Counselor, 9(5), 22–27.

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Introduction to Substance Use and Misuse Copyright © 2026 by Scott Coble and Carmelita L. Dotson is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.